Healthcare | August 28, 2023
IBL Healthcare invests in KNISS Laboratories
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
The company is committed to address the observations and will submit its response to US FDA within the stipulated time
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
ABB India has secured an order from Reliance Life Sciences to deploy automation and control solutions for their new biosimilars and plasma proteins manufacturing facilities in Nashik, Maharashtra
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
The inspection was conducted from August 7 to August 11, 2023 and concluded without any observations.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
